Clinical trial

Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer

NCT00054470

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2002-12-01

PhasePHASE2

Study timeline

Study start (unknown)2002-12-01Date precision: month

Registry last updated2012-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

trastuzumabBIOLOGICAL

tipifarnibDRUG

Sponsors & collaborators

The University of Texas Health Science Center at San Antoniolead sponsor

National Cancer Institute (NCI)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00054470 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.